Categories
Pharmaceutical

Worldwide Demand For Diabetic Neuropathy Has Anticipated To Grow At A CAGR Of 5.6% By 2025 | Fact.MR Forecasts

Diabetic Neuropathy Market Forecast, Trend, Analysis & Competition Tracking By Disorder (Peripheral, Autonomic, Proximal, Focal), By Treatment (Drugs, Analgesic, Antidepressants, Anticonvulsant Drugs, Radiotherapy) – Global Market Insights  2025

Another drug, Lyrica, has also been approved for neuropathic pain treatment in 130 countries. On the back of these trends, global diabetic neuropathy market is anticipated to grow at a CAGR of 5.6% during the forecast period (2020-2025).

To remain ‘ahead’ of your competitors, request a sample:

https://www.factmr.com/connectus/sample?flag=S&rep_id=4698

Global Diabetic Neuropathy Market Segmentation

Fact.MR has studied the global diabetic neuropathy market with detailed segmentation on the basis of disorder, treatment, distribution channel and region.

  • Disorder
    • Peripheral Neuropathy
    • Autonomic Neuropathy
    • Proximal Neuropathy
    • Focal Neuropathy
  • Treatment
    • Drugs
    • Analgesic
    • Topical:
      • Capsaicin
      • Others
    • Opioid:
      • Morphine
      • Others
    • NSAIDs:
      • Ibuprofen
      • Naproxen
      • Others
    • Antidepressants:
      • TCAs:
        • Amitriptyline
        • Imipramine
        • Others
      • SNRIs:
        • Duloxetine
        • Others
      • SSRIs:
        • Citalopram
        • Paroxetine
        • Others
    • Anticonvulsant Drugs:
      • Gabapentin
      • Pregabalin
      • Topiramate
      • Others
    • Other Drugs
  • Radiotherapy:
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Others
    • Physiotherapy
  • Distribution Channel
    • Hospitals
    • Clinics
    • Retail Pharmacy
    • Online Pharmacy
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa (MEA)

Speak To Research Analyst For Detailed Insights:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=4698

The insights for each vendor consists of:

  • Company profile
  • SWOT analysis
  • Main market information
  • Market share
  • Revenue, pricing and gross margin

What insights does the Diabetic Neuropathy Market report provide to the readers?

  • Diabetic Neuropathy fragmentation on the basis of product type, end use, and region.
  • Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
  • Collaborations, R&D projects, acquisitions, and product launches of each Diabetic Neuropathy player.
  • Various regulations imposed by the governments on the consumption of Diabetic Neuropathy in detail.
  • Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global Diabetic Neuropathy.

Full Access of this Report Is Available at:

https://www.factmr.com/checkout/4698

The report covers following Diabetic Neuropathy Market insights and assessment that are helpful for all participants involved in the Diabetic Neuropathy market:

  • Data on recently introduced regulations and their impact on key industries and on demand in Diabetic Neuropathy
  • Latest industry Analysis on Diabetic Neuropathy Market, with key analysis of market drivers, trends, and influencing factors
  • Key trends Analysis of Diabetic Neuropathy Market and changing consumer preferences in major industries.
  • Changing Diabetic Neuropathy demand and consumption of diverse products
  • Major trends underlining funding by key investors in numerous countries
  • New investment opportunities in diverse technology and product or service types
  • Comprehensive data and Competitive analysis of Diabetic Neuropathy major players
  • Diabetic Neuropathy Market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
  • Diabetic Neuropathy demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth

Questionnaire answered in the Diabetic Neuropathy Market report include:

  • How the market for Diabetic Neuropathy has grown?
  • What is the present and future outlook of the global Diabetic Neuropathy on the basis of region?
  • What are the challenges and opportunities for the Diabetic Neuropathy?
  • Why the consumption of Diabetic Neuropathy highest in region?
  • In which year segment is expected to overtake segment?

Read Our Latest Article on Healthcare Domain 

https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

contact:

21st floor , 136 Sejong-daero,
Seoul,100-768
South Korea
Phone: +1 (628) 251-1583
Email: sales@factmr.com

Categories
Pharmaceutical

Approval of Novel Drugs to Push Revenue Growth of Diabetic Neuropathy Opioids Market – Fact.MR Study

250 Pages Diabetic Neuropathy Opioids Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Diabetic Neuropathy Opioids to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Diabetic Neuropathy Opioids market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=4698

 

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Diabetic Neuropathy Opioids market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Diabetic Neuropathy Opioids

The report offers actionable and valuable market insights of Diabetic Neuropathy Opioids. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Diabetic Neuropathy Opioids Market across various industries and regions.

diabetic neuropathy market size us$ forecast by disorder type

This newly published and insightful report sheds light on Market Insights of Diabetic Neuropathy Opioids, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Diabetic Neuropathy Opioids Market.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=4698

Global Diabetic Neuropathy Opioids Market Segmentation

Fact.MR has studied the global Diabetic Neuropathy Opioids market with detailed segmentation on the basis of disorder, treatment, distribution channel and region.

  • Disorder
    • Peripheral Neuropathy
    • Autonomic Neuropathy
    • Proximal Neuropathy
    • Focal Neuropathy
  • Treatment
    • Drugs:
    • Analgesic:
    • Topical:
      • Capsaicin
      • Others
    • Opioid:
      • Morphine
      • Others
    • NSAIDs:
      • Ibuprofen
      • Naproxen
      • Others
    • Antidepressants:
      • TCAs:
        • Amitriptyline
        • Imipramine
        • Others
      • SNRIs:
        • Duloxetine
        • Others
      • SSRIs:
        • Citalopram
        • Paroxetine
        • Others
    • Anticonvulsant Drugs:
      • Gabapentin
      • Pregabalin
      • Topiramate
      • Others
    • Other Drugs
  • Radiotherapy:
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Others
    • Physiotherapy
  • Distribution Channel
    • Hospitals
    • Clinics
    • Retail Pharmacy
    • Online Pharmacy
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/4698

Development of Novel Molecules and Drugs Remains Key Growth Stimuli for Market Players

The global diabetic neuropathy market is highly consolidated in nature. The key market players are Arbor Pharmaceuticals, LLC, Pfizer, Inc., Janssen Global Services, LLC, NeuroMatrix, Inc., Depomed, Inc., and Eli Lilly. These companies primarily concentrate on developing new drugs within their pipeline, owing to increased need for treatment of diabetics.

Janssen Global Services, LLC, the pharmaceutical arm of Johnson & Johnson, manufactures diabetic neuropathy drugs such as NUCYNTA, NUCYNTA ER, Duragesic and INVOKANA. These drugs contain canagliflozin and tapentadol which are important for regulating blood sugar levels. Likewise, Pfizer, Inc. produces Lyrica EH, Celebrex, Lyrica IH and Tafamidis Meglumine.

Key Takeaways of Global Diabetic Neuropathy Opioids Market Study:

  • By disorder type, the peripheral neuropathy segment is poised to register positive growth, capturing more than half of the global Diabetic Neuropathy Opioids market. Current limitations of Diabetic Neuropathy Opioids treatment and underdiagnoses of patients are anticipated to leverage the segment’s growth. Present treatment is largely restricted to managing pain instead of regeneration of nerves.
  • Proximal neuropathy shall also find substantial application in Diabetic Neuropathy Opioids formulations. This is attributed to an increasing patient pool suffering from type 2 diabetes. Projections indicate a market share of nearly a quarter of the global Diabetic Neuropathy Opioids market, growing at a CAGR of 5.6% during the forecast period.
  • By treatment type, the drugs segment is poised to register maximum growth, expanding 1.4x and capturing more than four-fifths of the global Diabetic Neuropathy Opioids market. This is attributed to rising consumption of antidepressant and analgesic categories. Analgesics, particularly opioids, are effective painkillers, thus surging their popularity.
  • By distribution channel, online pharmacies are set to surge in popularity, attributed to increase in digital sales and a flourishing e-commerce industry. Several governments are supporting the concept of e-pharmacy as it is very convenient for patients in terms of cost and delivery. The segment is projected to expand 1.3x during the forecast period.
  • By region, North America is projected to capture greater than two-fifth of the Diabetic Neuropathy Opioids market. Increasing percentage of patients getting diagnosed and receiving treatment for Diabetic Neuropathy Opioids and government efforts to fund research for new drugs and therapies shall drive growth. The region shall expand 1.4x during the forecast period.
  • Asia-Pacific shows healthy growth prospects, owing to a large population base, poor dietary habits and limited healthcare infrastructure. The region is anticipated to expand 1.5x, capturing over one-fifth of the global Diabetic Neuropathy Opioids market during the forecast period.
  • The COVID-19 pandemic is anticipated to create delays in processing orders, owing to a shift towards a remote workforce. However, supply chain disruptions are not anticipated. Key manufacturers are working tirelessly to ensure that essential drugs are supplied as quickly as possible to hospitals. For this, many companies have suggested that hospitals and pharmacies purchase products directly from the wholesalers.

 

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Diabetic Neuropathy Opioids Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Diabetic Neuropathy Opioids Historical volume analysis: The report provides a comparison of Diabetic Neuropathy Opioids’s historical sales and projected sales performance for 2021-2031.
  • Diabetic Neuropathy Opioids Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Diabetic Neuropathy Opioids market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Diabetic Neuropathy Opioids Consumption by demographics: The report investigates consumer behavior affecting Diabetic Neuropathy Opioids demand outlook for the assessment period. Effect of their keenness for digital trends on Diabetic Neuropathy Opioids market is carefully analyzed
  • Post COVID consumer spending on Diabetic Neuropathy Opioids: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Diabetic Neuropathy Opioids market growth.

More Valuable Insights on Diabetic Neuropathy Opioids Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Diabetic Neuropathy Opioids, Sales and Demand of Diabetic Neuropathy Opioids, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

 

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Diabetic Neuropathy Market To Receive Overwhelming Hike In Revenues By 2022 – 2031

The latest research report published by Fact.MR on the Survey of Diabetic Neuropathy Market is intended to offer reliable data on various key factors shaping the growth curve & outlook of Diabetic Neuropathy market. This report works as a rich source of information for key entities such as policy makers, end-use industries, investors, and opinion leaders.

The Demand analysis of Diabetic Neuropathy Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Diabetic Neuropathy Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=4698

The Market survey of Diabetic Neuropathy offers a comprehensive analysis of diverse features, including production capacities analysis of Diabetic Neuropathy, demand, product developments, revenue generation, and Size of Diabetic Neuropathy Market across the globe.

Global Diabetic Neuropathy Market Segmentation

Fact.MR has studied the global diabetic neuropathy market with detailed segmentation on the basis of disorder, treatment, distribution channel and region.

  • Disorder
    • Peripheral Neuropathy
    • Autonomic Neuropathy
    • Proximal Neuropathy
    • Focal Neuropathy
  • Treatment
    • Drugs
    • Analgesic
    • Topical:
      • Capsaicin
      • Others
    • Opioid:
      • Morphine
      • Others
    • NSAIDs:
      • Ibuprofen
      • Naproxen
      • Others
    • Antidepressants:
      • TCAs:
        • Amitriptyline
        • Imipramine
        • Others
      • SNRIs:
        • Duloxetine
        • Others
      • SSRIs:
        • Citalopram
        • Paroxetine
        • Others
    • Anticonvulsant Drugs:
      • Gabapentin
      • Pregabalin
      • Topiramate
      • Others
    • Other Drugs
  • Radiotherapy:
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Others
    • Physiotherapy
  • Distribution Channel
    • Hospitals
    • Clinics
    • Retail Pharmacy
    • Online Pharmacy
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=4698

Some Notable Offerings by Fact.MR Report on Diabetic Neuropathy market:

  • MR will provide you an analysis of the extent to which this Diabetic Neuropathy market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • MR will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

Some of the Diabetic Neuropathy Market insights and estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides: 

  • Details regarding latest innovations and development in Diabetic Neuropathy and how it is gaining customer traction during the forecast period.
  • Analysis about the customer demand of the products and how it is likely to evolve in coming years.
  • Latest regulations enforced by government bodies and local agencies and their impact on Demand of Diabetic Neuropathy Market .
  • Insights about adoption of new technologies and its influence on the Diabetic Neuropathy market Size.
  • Overview of the impact of COVID-19 on Diabetic Neuropathy Market and economic disruptions caused by the pandemic.
  • Evaluates post-pandemic impact on the Sales of Diabetic Neuropathy Market during the forecast period.

To get all-in insights on the regional landscape of the Diabetic Neuropathy Market, buy now:-https://www.factmr.com/checkout/4698

After reading the Market insights of Diabetic Neuropathy Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Diabetic Neuropathy market revenue.
  • Study the growth outlook of Diabetic Neuropathy market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Diabetic Neuropathy market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Diabetic Neuropathy Market Players.

How Fact.MR Assists in Making Strategic Moves For Diabetic Neuropathy Market Manufacturer?

  • The data provided in the Diabetic Neuropathy market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

Read More Trending Reports of Fact.MR: – https://www.biospace.com/article/global-venous-procedure-devices-market-to-exceed-valuation-of-us-3-billion-by-2031-fact-mr/

About Fact.MR:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

 Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Demand for Diabetic Peripheral Neuropathy Is Expected To Grow At A CAGR of 5.9% Over The Assessment Period

170 Pages of Market Research Survey Report Published by Fact.MR, A Market Research and Competitive Intelligence Provider Highlights Key Factors Driving the Growth of Diabetic Neuropathy Market Over the Forecast Period 2020-2025

The Fact.MR study on the Diabetic Neuropathy market offers insights into key factors affecting market growth trajectory. The survey report reveals insights into drivers propelling the demand outlook in terms of Treatment, Disorder, and Distribution Channel. The report also highlights the scope of Diabetic Neuropathy over the assessment period

The incidence of diabetes has increased globally. As of 2019, nearly one-tenth of the global population was afflicted by this deadly disease. Adoption of sedentary lifestyles and a decline in the consumption of a balanced diet are key drivers behind this rising prevalence. As a result, the number of patients seeking treatment has also increased. Various pharmaceutical companies are investing in anti-diabetic drugs to address this problem. Drugs are further receiving an uptick among diabetic patients afflicted by COVID-19 to reduce fatalities.

For detailed insights on enhancing your product footprint, request a sample here-  https://www.factmr.com/connectus/sample?flag=S&rep_id=4698

The introduction of novel drugs such as Nucynta ER and Lyrica are anticipated to be major growth drivers for the global diabetic neuropathy market. Moreover, rising insurance coverage to neuropathic pain drug companies will also market prospects. The global diabetic neuropathy market is poised to expand at a CAGR of 5.6% across the forecast period (2020-2025).

“The global diabetic neuropathy market shows healthy growth prospects in the future. Approval of new drugs for treatment by agencies such as the FDA has prompted key manufacturers to increase their product pipeline. This is anticipated to steer the market in a positive direction,” concludes a Fact.MR analyst.

diabetic neuropathy market increment opportunity assessment by region

Key Takeaways of Global Diabetic Neuropathy Market Study:

  • By disorder type, the peripheral neuropathy segment is poised to register positive growth, capturing more than half of the global diabetic neuropathy market. Current limitations of diabetic neuropathy treatment and underdiagnoses of patients are anticipated to leverage the segment’s growth. Present treatment is largely restricted to managing pain instead of regeneration of nerves.
  • Proximal neuropathy shall also find substantial application in diabetic neuropathy formulations. This is attributed to an increasing patient pool suffering from type 2 diabetes. Projections indicate a market share of nearly a quarter of the global diabetic neuropathy market, growing at a CAGR of 5.6% during the forecast period.
  • By treatment type, the drugs segment is poised to register maximum growth, expanding 1.4x and capturing more than four-fifths of the global diabetic neuropathy market. This is attributed to rising consumption of antidepressant and analgesic categories. Analgesics, particularly opioids, are effective painkillers, thus surging their popularity.
  • By distribution channel, online pharmacies are set to surge in popularity, attributed to increase in digital sales and a flourishing e-commerce industry. Several governments are supporting the concept of e-pharmacy as it is very convenient for patients in terms of cost and delivery. The segment is projected to expand 1.3x during the forecast period.
  • By region, North America is projected to capture greater than two-fifth of the diabetic neuropathy market. Increasing percentage of patients getting diagnosed and receiving treatment for diabetic neuropathy and government efforts to fund research for new drugs and therapies shall drive growth. The region shall expand 1.4x during the forecast period.
  • Asia-Pacific shows healthy growth prospects, owing to a large population base, poor dietary habits and limited healthcare infrastructure. The region is anticipated to expand 1.5x, capturing over one-fifth of the global diabetic neuropathy market during the forecast period.
  • The COVID-19 pandemic is anticipated to create delays in processing orders, owing to a shift towards a remote workforce. However, supply chain disruptions are not anticipated. Key manufacturers are working tirelessly to ensure that essential drugs are supplied as quickly as possible to hospitals. For this, many companies have suggested that hospitals and pharmacies purchase products directly from the wholesalers.

Have a Query? Speak to Research Analyst https://www.factmr.com/connectus/sample?flag=AE&rep_id=4698

Global Diabetic Neuropathy Market Segmentation

Fact.MR has studied the global diabetic neuropathy market with detailed segmentation on the basis of disorder, treatment, distribution channel and region.

  • Disorder
    • Peripheral Neuropathy
    • Autonomic Neuropathy
    • Proximal Neuropathy
    • Focal Neuropathy
  • Treatment
    • Drugs:
    • Analgesic:
    • Topical:
      • Capsaicin
      • Others
    • Opioid:
      • Morphine
      • Others
    • NSAIDs:
      • Ibuprofen
      • Naproxen
      • Others
    • Antidepressants:
      • TCAs:
        • Amitriptyline
        • Imipramine
        • Others
      • SNRIs:
        • Duloxetine
        • Others
      • SSRIs:
        • Citalopram
        • Paroxetine
        • Others
    • Anticonvulsant Drugs:
      • Gabapentin
      • Pregabalin
      • Topiramate
      • Others
    • Other Drugs
  • Radiotherapy:
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Others
    • Physiotherapy
  • Distribution Channel
    • Hospitals
    • Clinics
    • Retail Pharmacy
    • Online Pharmacy
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa (MEA)

Full Access of this Report Is Available at https://www.factmr.com/checkout/4698

Molecular Development, Product Launches Act as Key Growth Levers

The global diabetic neuropathy market consists of the following players: Arbor Pharmaceuticals, LLC, Pfizer, Inc., Janssen Global Services, LLC, NeuroMatrix, Inc., Depomed, Inc., and Eli Lilly. These companies primarily concentrate on developing new drugs within their pipeline, owing to the burgeoning need for treatment of diabetes.

Janssen Global Services, LLC, the pharmaceutical arm of Johnson & Johnson, manufactures diabetic neuropathy drugs such as NUCYNTA, NUCYNTA ER, Duragesic and INVOKANA. These drugs contain canagliflozin and tapentadol which are important for regulating blood sugar levels. Likewise, Pfizer, Inc., produces Lyrica EH, Celebrex, Lyrica IH and TafamidisMeglumine.

Another prominent market player, Glenmark Pharmaceuticals Ltd., manufactures remoglifozin etabonate, belonging to the gliflozin class to treat type-2 diabetes. Additionally, the company has successfully out-licensed seven novel molecules to leading pharmaceutical giants such as Merck KGaA and remains the only company to execute multiple deals on novel molecules. An example of this is the development of the SGLT2 inhibitor which developed into remoglifozin.

For More Trending Insights of Fact.MR https://www.biospace.com/article/with-growing-number-of-pet-parents-and-care-awareness-heartworm-treatment-market-is-witnessing-promising-growth/

Looking for more information?

The research study on the global diabetic neuropathy market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global diabetic neuropathy market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of disorder type (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy and Focal Neuropathy), treatment type (Drugs, Radiotherapy and Physiotherapy) and distribution channel (Hospitals, Clinics, Retail Pharmacy and Online Pharmacy) across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com